
  
    
      
        Background_NNP
        FtsZ_NNP assembles_NNS into_IN protofilaments_NNS in_IN vitro_NN [_NN 1_CD ,_, 2_CD ,_, 3_CD ,_,
        4_CD ]_NN ,_, and_CC these_DT are_VBP thought_VBN to_TO form_VB the_DT cytoskeletal_NN
        framework_NN of_IN the_DT bacterial_JJ cell_NN division_NN machine_NN of_IN
        prokaryotes_NNS [_NN 5_CD ,_, 6_CD ,_, 7_CD ]_NN ._. The_DT FtsZ_NNP protein_NN is_VBZ homologous_RB to_TO
        tubulin_NN ,_, and_CC the_DT orientation_NN of_IN FtsZ_NNP subunits_NNS in_IN the_DT
        protofilament_NN can_MD be_VB deduced_JJ by_IN comparing_VBG the_DT atomic_JJ
        structures_NNS of_IN tubulin_NN and_CC FtsZ_NNP [_NN 8_CD ,_, 9_CD ,_, 10_CD ]_NN ._. If_IN the_DT tubulin_NN
        subunit_NN is_VBZ thought_VBN of_IN as_IN a_DT cube_NN ,_, it_PRP would_MD have_VB six_CD faces_NNS ._.
        The_DT top_NN and_CC bottom_NN faces_NNS of_IN the_DT subunit_NN ,_, which_WDT we_PRP call_VBP
        longitudinal_NN ,_, contact_NN subunits_NNS above_IN and_CC below_IN it_PRP in_IN the_DT
        protofilament_NN ;_: the_DT right_NN and_CC left_VBD faces_VBZ ,_, which_WDT we_PRP call_VBP
        lateral_NN ,_, contact_NN subunits_NNS in_IN adjacent_JJ protofilaments_NNS ;_: and_CC
        the_DT front_NN and_CC back_RB faces_VBZ correspond_VB to_TO the_DT outside_JJ and_CC
        inside_IN of_IN the_DT microtubule_NN ._. Since_IN the_DT FtsZ_NNP protofilament_NN
        appears_VBZ to_TO be_VB a_DT homolog_NN of_IN the_DT tubulin_NN protofilament_NN [_NN 2_CD ,_,
        11_CD ]_NN we_PRP will_MD use_VB these_DT same_JJ designations_NNS for_IN FtsZ_NNP ._.
        To_TO identify_VB amino_JJ acids_NNS critical_JJ for_IN FtsZ_NNP function_NN ,_, we_PRP
        constructed_VBN 16_CD mutations_NNS ,_, mostly_RB changing_VBG conserved_JJ
        aspartate_NN and_CC glutamate_NN residues_NNS to_TO alanine_NN ._. Initially_RB we_PRP
        selected_VBD amino_JJ acids_NNS for_IN mutation_NN based_VBN on_IN conservation_NN
        across_IN different_JJ species_NNS ,_, but_CC after_IN the_DT atomic_JJ structure_NN of_IN
        FtsZ_NNP was_VBD determined_VBN [_NN 8_CD ]_NN we_PRP designed_VBD other_JJ mutations_NNS to_TO
        target_VB specific_JJ structural_JJ questions_NNS ._. The_DT main_JJ focus_NN of_IN the_DT
        present_JJ study_NN was_VBD to_TO characterize_VB the_DT in_IN vitro_NN assembly_NN and_CC
        GTPase_NNP of_IN the_DT mutant_JJ proteins_NNS ,_, but_CC we_PRP also_RB did_VBD a_DT
        preliminary_JJ survey_NN of_IN their_PRP$ in_IN vivo_NN function_NN by_IN testing_VBG
        their_PRP$ ability_NN to_TO complement_VB the_DT temperature_NN sensitive_JJ
        mutant_JJ 
        ftsZ_NN 84_CD ._. 
        More_JJR than_IN a_DT dozen_NN mutations_NNS of_IN FtsZ_NNP have_VBP been_VBN
        characterized_VBN in_IN previous_JJ studies_NNS ._. We_PRP include_VBP these_DT
        previously_RB characterized_VBN mutations_NNS in_IN our_PRP$ analysis_NN of_IN the_DT
        structurally_RB important_JJ side_NN chains_NNS of_IN FtsZ_NNP ._.
      
      
        Results_NNS
        
          Expression_NNP of_IN mutant_JJ proteins_NNS
          We_PRP made_VBD 16_CD site_NN directed_VBD mutants_NNS of_IN 
          E_NNP ._. coli_NNS FtsZ_NNP ._. The_DT amino_JJ acids_NNS
          mutated_VBN were_VBD all_DT exposed_VBN on_IN the_DT surface_NN ,_, and_CC their_PRP$
          positions_NNS are_VBP mapped_VBN on_IN the_DT atomic_JJ structure_NN of_IN 
          Methanococcus_NNP FtsZ_NNP in_IN Fig_NNP ._. 1_LS ._. Their_PRP$
          locations_NNS are_VBP also_RB indicated_VBN in_IN Table_NNP 1_CD ._. The_DT mutant_JJ
          proteins_NNS were_VBD expressed_VBN in_IN the_DT pET_NN expression_NN system_NN ,_,
          where_WRB all_DT gave_VBD medium_NN or_CC high_JJ levels_NNS of_IN expression_NN ._. Some_DT
          proteins_NNS were_VBD partly_RB or_CC largely_RB insoluble_JJ when_WRB expressed_VBD
          in_IN BL_NNP 21_CD (_( DE_NNP 3_LS )_) ,_, but_CC all_DT were_VBD soluble_JJ when_WRB expressed_VBD in_IN the_DT
          mutant_JJ BL_NNP 21_CD strain_NN C_NNP 41_CD [_NN 12_CD ]_NN ._.
          Since_IN we_PRP were_VBD mutating_VBG only_RB surface-exposed_JJ charged_VBN
          groups_NNS ,_, we_PRP expected_VBD that_IN the_DT mutant_JJ proteins_NNS would_MD fold_VB
          normally_RB ._. One_CD mutant_JJ protein_NN ,_, E_NNP 274_CD A_DT was_VBD completely_RB
          inactive_JJ in_IN assembly_NN ,_, GTPase_NNP activity_NN and_CC in_IN vivo_NN
          function_NN ._. Gel_NNP filtration_NN and_CC sedimentation_NN showed_VBD that_IN
          this_DT protein_NN was_VBD aggregated_JJ ,_, and_CC the_DT loss_NN of_IN activity_NN may_MD
          be_VB a_DT consequence_NN of_IN this_DT aggregation_NN ,_, rather_RB than_IN the_DT
          specific_JJ location_NN of_IN the_DT mutation_NN ._. E_NNP 274_CD A_DT is_VBZ not_RB included_VBN
          in_IN Table_NNP 1_CD or_CC Fig_NNP ._. 1_LS ._. The_DT best_JJS evidence_NN that_IN the_DT other_JJ
          mutant_JJ proteins_NNS are_VBP properly_RB folded_VBN is_VBZ that_IN every_DT one_CD of_IN
          them_PRP assembled_VBD in_IN the_DT presence_NN of_IN DEAE_NNP dextran_NN into_IN
          specific_JJ polymers_NNS recognizable_JJ by_IN electron_NN
          microscopy_NN ._.
        
        
          In_IN vivo_NN complementation_NN tests_NNS
          A_DT complementation_NN system_NN consisting_VBG of_IN 
          E_NNP ._. coli_NNS strain_VBP JFL_NNP 101_CD (_( 
          ftsZ_NN 84_CD (_( ts_NNS )_) )_) and_CC plasmid_NN pBS_NN 58_CD [_NN
          13_CD ]_NN was_VBD used_VBN to_TO test_VB the_DT ability_NN of_IN our_PRP$ mutant_JJ FtsZs_NNP to_TO
          support_VB cell_NN division_NN ._. JFL_NNP 101_CD carries_VBZ the_DT temperature_NN
          sensitive_JJ 
          ftsZ_NN 84_CD mutation_NN at_IN the_DT genomic_JJ
          locus_JJ ,_, and_CC is_VBZ unable_JJ to_TO divide_VB at_IN 42_CD °_NN C_NNP ,_, although_IN it_PRP can_MD
          grow_VB and_CC divide_VB normally_RB at_IN 30_CD °_NN C_NNP ._. pBS_NN 58_CD is_VBZ a_DT very_RB low_JJ
          copy_NN plasmid_NN carrying_VBG a_DT genomic_JJ fragment_NN containing_VBG 
          ftsQ_NN ,_, 
          ftsA_NN and_CC 
          ftsZ_NN ,_, and_CC all_DT of_IN the_DT relevant_JJ
          promoters_NNS ._. This_DT supplies_VBZ a_DT 2_CD -_: 3_CD fold_VB excess_NN of_IN FtsZ_NNP (_( and_CC
          also_RB FtsQ_NNP and_CC FtsA_NNP )_) and_CC complements_VBZ 
          ftsZ_NN 84_CD ,_, permitting_VBG cell_NN growth_NN and_CC
          division_NN at_IN 42_CD °_NN C_NNP when_WRB carried_VBD in_IN JFL_NNP 101_CD [_NN 13_CD ]_NN ._.
          Each_DT of_IN our_PRP$ mutations_NNS was_VBD transferred_VBN from_IN pET_NN into_IN
          the_DT 
          ftsZ_NN gene_NN of_IN pBS_NN 58_CD ._. These_DT mutants_NNS
          in_IN pBS_NN 58_CD were_VBD tested_VBN for_IN the_DT ability_NN to_TO complement_VB the_DT 
          ftsZ_NN 84_CD (_( ts_NNS )_) mutation_NN of_IN JFL_NNP 101_CD ,_,
          supporting_VBG growth_NN and_CC division_NN when_WRB grown_VBN in_IN liquid_JJ LB_NNP
          containing_VBG 1_CD %_NN NaCl_NNP with_IN 100_CD μg_NN /_NN mL_NN spectinomycin_NN ._. Cells_NNP
          that_WDT showed_VBD prominent_JJ filamentation_NN and_CC inability_NN to_TO
          generate_VB a_DT turbid_NN culture_NN after_IN overnight_JJ growth_NN at_IN 42_CD °_NN C_NNP
          were_VBD designated_VBN non-complementing_JJ ._. The_DT results_NNS of_IN the_DT
          complementation_NN tests_NNS are_VBP given_VBN in_IN Table_NNP 1_CD ._.
          We_PRP used_VBD quantitative_JJ western_JJ blotting_VBG to_TO check_VB the_DT
          level_NN of_IN expression_NN from_IN the_DT pBS_NN 58_CD plasmid_NN (_( Fig_NNP ._. 2_LS )_) ._. We_PRP
          first_RB found_VBD that_IN the_DT level_NN of_IN FtsZ_NNP expression_NN was_VBD
          approximately_RB the_DT same_JJ in_IN three_CD strains_NNS of_IN 
          E_NNP ._. coli_NNS at_IN both_DT 30_CD and_CC 42_CD °_NN C_NNP ._. pBS_NN 58_CD
          with_IN wild_JJ type_NN 
          ftsZ_NN caused_VBD a_DT three-_NN to_TO fivefold_JJ
          increase_NN in_IN total_JJ FtsZ_NNP levels_NNS when_WRB transformed_VBN into_IN
          MC_NNP 1000_CD or_CC JFL_NNP 101_CD ,_, consistent_JJ with_IN the_DT previous_JJ report_NN [_NN
          13_CD ]_NN ._. pBS_NN 58_CD carrying_VBG four_CD of_IN the_DT benign_JJ mutations_NNS caused_VBD a_DT
          similar_JJ 3_CD -_: 5_CD -_: fold_VB increase_NN in_IN total_JJ FtsZ_NNP ._. These_DT plasmids_NNS
          all_DT complemented_JJ the_DT temperature_NN sensitive_JJ 
          ftsZ_NN 84_CD mutation_NN in_IN JFL_NNP 101_CD ._. However_RB ,_,
          seven_CD mutants_NNS that_WDT failed_VBD to_TO complement_VB showed_VBD total_JJ FtsZ_NNP
          levels_NNS approximately_RB equal_VBP to_TO that_DT from_IN cells_NNS without_IN
          pBS_NN 58_CD ,_, implying_VBG that_DT expression_NN from_IN the_DT plasmid_NN was_VBD
          severely_RB reduced_VBN ._.
          The_DT failure_NN to_TO complement_VB 
          ftsZ_NN 84_CD at_IN the_DT non-restrictive_JJ
          temperature_NN can_MD therefore_RB be_VB attributed_VBN to_TO the_DT low_JJ
          expression_NN ,_, but_CC the_DT important_JJ question_NN is_VBZ why_WRB the_DT
          expression_NN has_VBZ been_VBN so_RB reduced_VBN ._. A_DT likely_JJ explanation_NN is_VBZ
          that_IN these_DT mutant_JJ FtsZs_NNP are_VBP toxic_JJ at_IN 30_CD °_NN C_NNP ,_, so_IN that_IN the_DT
          only_JJ clones_NNS obtained_VBN are_VBP ones_NNS that_WDT have_VBP altered_VBN the_DT pBS_NN 58_CD
          plasmid_NN to_TO reduce_VB expression_NN ._. Consistent_NNP with_IN this_DT ,_,
          clones_NNS of_IN pBS_NN 58_CD carrying_VBG D_NNP 96_CD A_DT and_CC D_NNP 166_CD K_NNP /_NN F_NN 268_CD V_NNP showed_VBD
          aberrant_NN Z-_NNP ring_NN formation_NN at_IN 30_CD °_NN C_NNP ,_, and_CC E_NNP 250_CD K_NNP /_NN D_NNP 253_CD K_NNP showed_VBD
          fragility_NN and_CC cell_NN lysis_NNS ._. This_DT suggests_VBZ that_IN the_DT mutant_JJ
          protein_NN is_VBZ expressed_VBN at_IN a_DT low_JJ level_NN ,_, and_CC it_PRP has_VBZ a_DT toxic_JJ
          effect_NN ._.
          That_DT wild_JJ type_NN 
          ftsZ_NN and_CC four_CD benign_JJ mutants_NNS gave_VBD
          substantial_JJ expression_NN from_IN pBS_NN 58_CD ,_, while_IN expression_NN was_VBD
          repressed_JJ in_IN seven_CD non-complementing_JJ mutants_NNS ,_, suggests_VBZ
          that_IN many_JJ or_CC all_DT of_IN the_DT latter_JJ have_VBP dominant_JJ negative_JJ
          effects_NNS ._. These_DT results_NNS also_RB point_VBP to_TO the_DT limitations_NNS of_IN
          the_DT JFL_NNP 101_CD (_( pBS_NN 58_CD )_) system_NN to_TO characterize_VB phenotypes_NNS of_IN
          mutant_JJ 
          ftsZ_NN ._. This_DT plasmid_NN uses_VBZ the_DT
          endogenous_JJ 
          ftsZ_NN promoters_NNS ,_, which_WDT are_VBP
          constitutively_RB activated_VBN and_CC may_MD be_VB subject_JJ to_TO repression_NN
          by_IN second_JJ site_NN mutations_NNS ._. To_TO fully_RB characterize_VB the_DT in_IN
          vivo_NN phenotypes_NNS ,_, we_PRP are_VBP turning_VBG to_TO a_DT system_NN where_WRB
          expression_NN of_IN the_DT mutant_JJ protein_NN can_MD be_VB repressed_JJ for_IN
          cloning_VBG ,_, and_CC induced_VBD at_IN controlled_VBN levels_NNS for_IN phenotypic_JJ
          examination_NN ._. We_PRP will_MD also_RB test_VB whether_IN the_DT mutant_JJ 
          ftsZ_NN s_VBZ can_MD support_VB division_NN in_IN an_DT 
          ftsZ_NN null_NN ._. These_DT studies_NNS are_VBP in_IN
          progress_NN to_TO resolve_VB the_DT present_JJ uncertainty_NN of_IN the_DT
          phenotypes_NNS in_IN the_DT JFL_NNP 101_CD (_( pBS_NN 58_CD )_) system_NN ._.
        
        
          In_IN vitro_NN GTPase_NNP and_CC assembly_NN
          Table_NNP 1_CD summarizes_NNS the_DT GTPase_NNP and_CC assembly_NN properties_NNS
          of_IN the_DT mutant_JJ proteins_NNS ._. Data_NNP are_VBP also_RB included_VBN for_IN
          mutants_NNS characterized_VBN in_IN previous_JJ studies_NNS ._.
          GTPase_NNP activity_NN was_VBD characterized_VBN for_IN the_DT purified_JJ
          proteins_NNS in_IN MEMK_NNP 6_CD ._. 5_LS ,_, where_WRB wild_JJ type_NN FtsZ_NNP had_VBD a_DT GTPase_NNP
          activity_NN of_IN 6_CD ._. 5_CD mol_NN GDP_NNP per_IN mol_NN FtsZ_NNP per_IN min_NN [_NN 14_CD ]_NN ._. The_DT
          activity_NN of_IN mutant_JJ proteins_NNS is_VBZ expressed_VBN as_IN a_DT percent_NN of_IN
          the_DT wild_JJ type_NN activity_NN ._. Entries_NNP followed_VBN by_IN a_DT letter_NN in_IN
          parentheses_NNS are_VBP data_NNS from_IN other_JJ studies_NNS (_( the_DT letter_NN
          indicates_VBZ the_DT reference_NN ,_, see_VB footnote_NN to_TO the_DT table_NN )_) ._.
          FtsZ_NNP assembly_NN was_VBD tested_VBN in_IN MEMK_NNP 6_CD ._. 5_LS ,_, 1_CD mg_NN /_NN ml_NN FtsZ_NNP ,_, 2_CD
          mM_NN GTP_NNP or_CC GDP_NNP ,_, and_CC either_CC no_DT polycation_NN ,_, 20_CD mM_NN calcium_NN ,_,
          or_CC 0_CD ._. 06_CD or_CC 0_CD ._. 6_CD mg_NN /_NN ml_NN DEAE_NNP dextran_NN ._. Assembly_NNP was_VBD assayed_JJ
          by_IN negative_JJ stain_VB electron_NN microscopy_NN ,_, and_CC the_DT type_NN of_IN
          polymers_NNS assembled_VBN is_VBZ indicated_VBN for_IN each_DT condition_NN [_NN
          15_CD ]_NN ._.
          We_PRP need_VBP to_TO recall_VB that_IN the_DT polymers_NNS formed_VBN by_IN wild_JJ
          type_NN FtsZ_NNP with_IN DEAE_NNP dextran_NN and_CC GTP_NNP depend_VBP on_IN the_DT
          relative_JJ concentration_NN of_IN FtsZ_NNP and_CC polycation_NN [_NN 14_CD ,_, 15_CD ]_NN ._.
          At_IN 1_CD mg_NN /_NN ml_NN FtsZ_NNP ,_, 0_CD ._. 06_CD mg_NN /_NN ml_NN DEAE_NNP dextran_NN gives_VBZ sheets_NNS of_IN
          straight_JJ protofilaments_NNS ,_, whereas_IN with_IN 0_CD ._. 6_CD mg_NN /_NN ml_NN DEAE_NNP
          dextran_NN the_DT polymers_NNS were_VBD mostly_RB helical_JJ tubes_NNS ._. We_PRP have_VBP
          speculated_VBN that_IN at_IN 0_CD ._. 6_CD mg_NN /_NN ml_NN DEAE_NNP dextran_NN ,_, hydrolysis_NNS of_IN
          GTP_NNP may_MD occur_VB before_IN the_DT polymers_NNS are_VBP fully_RB formed_VBN and_CC
          rigidified_JJ ,_, allowing_VBG the_DT GDP-FtsZ_NNP to_TO adopt_VB the_DT curved_JJ
          conformation_NN ._. At_IN 0_CD ._. 06_CD mg_NN /_NN ml_NN DEAE_NNP dextran_NN on_IN the_DT other_JJ
          hand_NN ,_, straight_JJ protofilaments_NNS may_MD be_VB associated_VBN into_IN
          sheets_NNS faster_JJR than_IN hydrolysis_NNS ,_, and_CC lateral_NN contacts_NNS in_IN
          the_DT sheet_NN may_MD prevent_VB the_DT protofilaments_NNS from_IN adopting_VBG
          the_DT curved_JJ conformation_NN ._. Assembly_NNP in_IN GDP_NNP plus_CC 0_CD ._. 6_CD mg_NN /_NN ml_NN
          DEAE_NNP dextran_NN is_VBZ very_RB reproducible_JJ ,_, giving_VBG only_RB helical_JJ
          tubes_NNS [_NN 15_CD ]_NN ._.
          The_DT mutations_NNS are_VBP grouped_VBN into_IN three_CD classes_NNS ,_, based_VBN on_IN
          their_PRP$ ability_NN to_TO complement_VB 
          ftsZ_NN 84_CD and_CC their_PRP$ location_NN on_IN the_DT
          3_CD -_: D_NNP structure_NN of_IN the_DT protein_NN ._.
        
        
          Benign_NNP mutations_NNS
          The_DT first_JJ box_NN in_IN Table_NNP 1_CD lists_VBZ benign_JJ mutations_NNS ,_, which_WDT
          complement_VB 
          ftsZ_NN 84_CD and_CC are_VBP therefore_RB functional_JJ
          in_IN cell_NN division_NN ._. These_DT mutant_JJ proteins_NNS also_RB showed_VBD
          normal_JJ assembly_NN in_IN our_PRP$ in_IN vitro_NN assay_NN ._. However_RB ,_, D_NNP 269_CD A_DT had_VBD
          only_RB 10_CD %_NN of_IN the_DT wild_JJ type_NN GTPase_NNP activity_NN ._. Two_CD previously_RB
          characterized_VBN mutation_NN proteins_NNS ,_, A_DT 70_CD T_NN (_( FtsZ_NNP 1_LS )_) ,_, A_DT 81_CD V_NNP /_NN F_NN 268_CD C_NNP
          (_( FtsZ_NNP 100_CD )_) ,_, have_VBP comparably_RB reduced_VBN GTPase_NNP in_IN vitro_NN ,_, but_CC
          appear_VB to_TO be_VB fully_RB functional_JJ for_IN cell_NN division_NN ._.
          Most_JJS of_IN the_DT benign_JJ mutations_NNS are_VBP located_VBN on_IN the_DT front_NN
          or_CC back_RB of_IN the_DT FtsZ_NNP subunit_NN ,_, i_NNP ._. e_SYM ._. ,_, the_DT faces_NNS
          corresponding_JJ to_TO the_DT outside_JJ or_CC inside_IN of_IN the_DT microtubule_NN
          (_( Fig_NNP ._. 1_LS a_DT )_) ._. This_DT suggests_VBZ that_IN even_RB highly_RB conserved_JJ amino_JJ
          acids_NNS on_IN these_DT surfaces_VBZ may_MD not_RB be_VB crucial_JJ for_IN function_NN
          in_IN cell_NN division_NN ._.
        
        
          Mutations_NNP of_IN amino_JJ acids_NNS that_WDT contact_NN GTP_NNP
          Several_JJ of_IN our_PRP$ mutants_NNS had_VBD substantially_RB reduced_VBN
          GTPase_NNP activity_NN in_IN vitro_NN ,_, failed_VBD to_TO complement_VB 
          ftsZ_NN 84_CD ,_, and_CC mapped_VBN on_IN the_DT 3_CD -_: D_NNP
          structure_NN in_IN direct_JJ contact_NN with_IN the_DT GTP_NNP ._. Table_NNP 1_CD also_RB
          lists_VBZ several_JJ mutation_NN with_IN similar_JJ characteristics_NNS
          characterized_VBN in_IN other_JJ studies_NNS ._. G_NNP 105_CD S_NNP (_( FtsZ_NNP 84_CD )_) and_CC D_NNP 212_CD G_NNP
          (_( FtsZ_NNP 2_LS )_) were_VBD able_JJ to_TO function_VB in_IN cell_NN division_NN but_CC had_VBD
          temperature_NN sensitive_JJ and_CC other_JJ phenotypes_NNS ,_, so_RB were_VBD not_RB
          listed_VBN with_IN benign_JJ mutations_NNS ._.
          
          ftsZ_NN 85_CD is_VBZ temperature_NN sensitive_JJ for_IN
          Z-_NNP ring_NN assembly_NN and_CC division_NN in_IN vivo_NN [_NN 16_CD ]_NN ,_, but_CC neither_DT
          its_PRP$ GTPase_NNP nor_CC assembly_NN in_IN vitro_NN showed_VBD any_DT temperature_NN
          sensitivity_NN ._. Thus_RB de_IN Boer_NNP et_CC al_NN ._. [_NN 17_CD ]_NN reported_VBD that_IN the_DT
          GTPase_NNP activity_NN was_VBD essentially_RB the_DT same_JJ at_IN 30_CD ,_, 37_CD and_CC
          44_CD °_NN C_NNP ._. Our_PRP$ in_IN vitro_NN assembly_NN showed_VBD the_DT same_JJ products_NNS
          assembled_VBN at_IN 30_CD °_NN C_NNP and_CC 42_CD °_NN C_NNP (_( data_NNS not_RB shown_VBN )_) ._. FtsZ_NNP 84_CD
          produced_VBN normal_JJ sheets_NNS of_IN straight_JJ protofilaments_NNS in_IN 0_CD ._. 06_CD
          mg_NN /_NN ml_NN DEAE_NNP dextran_NN ,_, but_CC they_PRP were_VBD abnormal_JJ in_IN also_RB
          producing_VBG sheets_NNS at_IN 0_CD ._. 6_CD mg_NN /_NN ml_NN DEAE_NNP dextran_NN (_( with_IN GTP_NNP )_) ._. In_IN
          fact_NN ,_, the_DT sheets_NNS formed_VBN by_IN FtsZ_NNP 84_CD were_VBD exceptionally_RB
          large_JJ and_CC well_RB ordered_VBD (_( Fig_NNP ._. 3_LS a_DT )_) ._. Tubes_NNP could_MD be_VB obtained_VBN
          by_IN assembly_NN in_IN GDP_NNP ,_, but_CC it_PRP seems_VBZ that_IN when_WRB assembled_VBN in_IN
          GTP_NNP the_DT impaired_VBN hydrolysis_NNS favors_VBZ the_DT straight_JJ
          conformation_NN ._. We_PRP have_VBP not_RB yet_RB examined_VBD FtsZ_NNP 84_CD for_IN
          assembly_NN of_IN protofilaments_NNS in_IN GTP_NNP and_CC protofilament_NN
          sheets_NNS in_IN calcium_NN ._.
          A_DT cluster_NN of_IN mutations_NNS (_( N_NNP 207_CD ,_, D_NNP 209_CD ,_, D_NNP 212_CD )_) strongly_RB
          affecting_VBG GTPase_NNP activity_NN are_VBP located_VBN on_IN the_DT opposite_JJ
          side_NN of_IN the_DT subunit_NN from_IN the_DT GTP_NNP (_( Fig_NNP ._. 1_LS b_SYM )_) ._. This_DT short_JJ
          strand_NN of_IN polypeptide_NN ,_, which_WDT we_PRP call_VBP the_DT "_'' synergy_NN "_'' loop_NN ,_,
          apparently_RB contacts_NNS the_DT GTP_NNP molecule_NN of_IN the_DT subunit_NN
          beneath_IN it_PRP in_IN the_DT protofilament_NN and_CC contributes_VBZ essential_JJ
          residues_NNS to_TO the_DT hydrolysis_NNS mechanism_NN ._. (_( See_VB [_NN 5_CD ,_, 18_CD ]_NN for_IN
          an_DT expanded_VBN discussion_NN of_IN this_DT hypothesis_NNS and_CC references_NNS
          to_TO mutants_NNS of_IN tubulin_NN that_DT map_NN to_TO this_DT loop_NN ._. )_)
          D_NNP 209_CD A_DT showed_VBD a_DT novel_NN assembly_NN form_NN ._. In_IN GTP_NNP plus_CC 10_CD mM_NN
          EDTA_NNP ,_, or_CC in_IN 10_CD mM_NN GTP_NNP (_( which_WDT also_RB chelates_NNS the_DT Mg_NNP )_) ,_, the_DT
          D_NNP 209_CD A_DT protein_NN assembled_VBN into_IN protofilament_NN bundles_NNS that_WDT
          formed_VBD long_JJ spirals_NNS or_CC closed_VBD circular_JJ hoops_NNS (_( Fig_NNP ._. 3_LS d_SYM ,_, e_SYM )_) ._.
          Both_DT the_DT spirals_NNS and_CC the_DT hoops_NNS were_VBD about_IN 120_CD to_TO 150_CD nm_NN
          in_IN diameter_NN ._. These_DT structures_NNS seem_VBP to_TO be_VB closely_RB related_VBN
          to_TO each_DT other_JJ ,_, with_IN the_DT hoops_NNS being_VBG formed_VBN when_WRB the_DT
          protofilament_NN ends_VBZ join_VB after_IN one_CD turn_VB ._. In_IN 2_CD mM_NN GMPCPP_NNP ,_, a_DT
          slowly_RB hydrolyzable_JJ analog_NN of_IN GTP_NNP ,_, D_NNP 209_CD A_DT assembled_VBD a_DT
          mixture_NN of_IN hoops_NNS and_CC tubes_NNS (_( Fig_NNP ._. 3_LS f_SYM )_) ._.
          D_NNP 212_CD A_DT was_VBD also_RB tested_VBN in_IN 2_CD mM_NN GMPCPP_NNP ,_, where_WRB it_PRP made_VBD
          only_RB tubes_NNS in_IN most_JJS circumstances_NNS ._. However_RB ,_, in_IN 0_CD ._. 06_CD mg_NN /_NN ml_NN
          DEAE_NNP dextran_NN it_PRP made_VBD some_DT twin_JJ protofilaments_NNS ,_, which_WDT were_VBD
          quite_RB straight_JJ ._. D_NNP 209_CD A_DT could_MD also_RB make_VB straight_JJ ,_, single_JJ
          protofilaments_NNS in_IN the_DT absence_NN of_IN DEAE_NNP dextran_NN ,_, while_IN
          D_NNP 212_CD A_DT could_MD not_RB ._. Both_DT mutants_NNS assembled_VBD bundles_NNS of_IN
          straight_JJ protofilaments_NNS in_IN 20_CD mM_NN calcium_NN ._. This_DT
          demonstrates_VBZ that_IN the_DT synergy_NN loop_NN mutants_NNS can_MD make_VB
          straight_JJ protofilaments_NNS under_IN certain_JJ conditions_NNS ._.
          However_RB ,_, the_DT synergy_NN loop_NN mutants_NNS and_CC D_NNP 45_CD A_DT seem_VBP highly_RB
          shifted_VBN toward_IN the_DT curved_JJ conformation_NN ,_, even_RB when_WRB
          assembled_VBN with_IN GMPCPP_NNP ._.
          D_NNP 45_CD is_VBZ close_JJ to_TO and_CC probably_RB contacts_NNS the_DT γ-phosphate_JJ
          of_IN the_DT GTP_NNP ,_, and_CC was_VBD the_DT most_RBS severe_JJ of_IN this_DT group_NN of_IN
          mutations_NNS ._. The_DT alanine_NN substitution_NN reduced_VBD the_DT in_IN vitro_NN
          GTPase_NNP activity_NN to_TO 5_CD %_NN of_IN wild_JJ type_NN and_CC appeared_VBD to_TO
          eliminate_VB the_DT ability_NN to_TO form_VB straight_JJ protofilaments_NNS ,_,
          either_CC alone_RB or_CC with_IN 0_CD ._. 06_CD mg_NN /_NN ml_NN DEAE_NNP dextran_NN ._. This_DT mutant_JJ
          protein_NN could_MD still_RB assemble_VB into_IN curved_JJ protofilaments_NNS
          and_CC form_NN tubes_NNS ._.
        
        
          Mutations_NNP on_IN the_DT protofilament_NN sides_NNS (_( lateral_NN
          mutations_NNS )_)
          A_DT second_JJ group_NN of_IN mutants_NNS mapped_VBN to_TO the_DT sides_NNS of_IN the_DT
          subunits_NNS ,_, which_WDT we_PRP originally_RB believed_VBD to_TO be_VB the_DT surfaces_VBZ
          that_IN bond_NN protofilaments_NNS to_TO each_DT other_JJ in_IN the_DT
          protofilament_NN sheets_NNS (_( see_VB Discussion_NNP )_) ._. Three_CD of_IN these_DT
          were_VBD part_NN of_IN our_PRP$ original_JJ group_NN of_IN mutations_NNS ,_, changing_VBG
          conserved_JJ asp_NN or_CC glu_NN residues_NNS to_TO ala_NN ._. Three_CD others_NNS were_VBD
          designed_VBN to_TO make_VB very_RB disruptive_JJ changes_NNS in_IN the_DT presumed_VBN
          lateral_NN contacts_NNS ,_, changing_VBG D_NNP 166_CD to_TO K_NNP ,_, S_NNP 245_CD to_TO F_NN ,_, and_CC
          constructing_VBG a_DT double_JJ mutant_JJ E_NNP 250_CD K_NNP /_NN D_NNP 253_CD K_NNP ._. E_NNP 250_CD and_CC D_NNP 253_CD
          are_VBP adjacent_JJ to_TO a_DT hydrophobic_JJ pocket_NN formed_VBN by_IN the_DT highly_RB
          conserved_JJ sequence_NN PLL_NNP (_( D_NNP /_NN E_NNP )_) ._.
          The_DT lateral_NN mutants_NNS had_VBD mostly_RB normal_JJ GTPase_NNP activity_NN ,_,
          which_WDT was_VBD expected_VBN since_IN the_DT GTPase_NNP is_VBZ thought_VBN to_TO be_VB
          triggered_VBN by_IN assembly_NN into_IN protofilaments_NNS ,_, which_WDT does_VBZ not_RB
          involve_VB the_DT lateral_NN surfaces_VBZ ._. There_EX were_VBD two_CD major_JJ
          surprises_NNS with_IN these_DT lateral_NN mutants_NNS ._. First_LS ,_, they_PRP gave_VBD
          mostly_RB normal_JJ in_IN vitro_NN assembly_NN of_IN both_DT sheets_NNS and_CC tubes_NNS ,_,
          in_IN contrast_NN to_TO our_PRP$ design_NN goal_NN to_TO disrupt_VB lateral_NN
          interactions_NNS of_IN protofilaments_NNS ._. Second_JJ ,_, all_DT of_IN the_DT
          lateral_NN mutants_NNS were_VBD incapable_JJ of_IN complementing_VBG the_DT 
          ftsZ_NN 84_CD mutation_NN ._. These_DT points_NNS are_VBP
          addressed_VBN in_IN the_DT Discussion_NNP ._.
          D_NNP 86_CD K_NNP had_VBD an_DT interesting_JJ assembly_NN property_NN ,_, in_IN that_IN it_PRP
          showed_VBD a_DT strong_JJ tendency_NN to_TO assemble_VB into_IN tubes_NNS ._. In_IN the_DT
          complete_JJ absence_NN of_IN DEAE_NNP dextran_NN ,_, D_NNP 86_CD K_NNP assembled_VBD into_IN
          tubes_NNS in_IN GDP_NNP or_CC without_IN added_JJ nucleotide_NN (_( Fig_NNP ._. 3_LS b_SYM )_) ._. In_IN
          fact_NN ,_, D_NNP 86_CD K_NNP was_VBD largely_RB assembled_VBN into_IN tubes_NNS when_WRB released_VBN
          from_IN the_DT expressing_VBG bacteria_NNS ._. In_IN the_DT presence_NN of_IN GTP_NNP ,_,
          D_NNP 86_CD K_NNP formed_VBD a_DT mixture_NN of_IN tubes_NNS and_CC straight_JJ twin_JJ
          protofilament_NN pairs_NNS (_( Fig_NNP ._. 3_LS c_SYM )_) ._. Wild_NNP type_NN FtsZ_NNP also_RB formed_VBD
          twin_JJ protofilaments_NNS ,_, but_CC their_PRP$ occurrence_NN was_VBD exaggerated_VBN
          with_IN D_NNP 86_CD K_NNP ._. D_NNP 86_CD K_NNP could_MD also_RB form_VB protofilament_NN sheets_NNS when_WRB
          assembled_VBN in_IN DEAE_NNP dextran_NN ,_, as_IN could_MD all_DT of_IN the_DT other_JJ
          lateral_NN mutants_NNS (_( Table_NNP 1_LS )_) ._. D_NNP 166_CD K_NNP had_VBD a_DT lower_JJR GTPase_NNP and_CC
          did_VBD not_RB assemble_VB as_IN well_RB ,_, but_CC this_DT may_MD have_VB been_VBN due_JJ to_TO
          problems_NNS in_IN the_DT protein_NN purification_NN ._.
        
      
      
        Discussion_NNP
        
          High_NNP GTPase_NNP is_VBZ not_RB essential_JJ for_IN cell_NN
          division_NN
          Several_JJ mutations_NNS reduce_VBP the_DT GTPase_NNP activity_NN to_TO 5_CD -_: 15_CD %_NN
          of_IN wild_JJ type_NN as_IN measured_VBN in_IN vitro_NN ,_, yet_RB can_MD still_RB support_VB
          cell_NN division_NN ._. Best_RBS studied_VBN is_VBZ 
          ftsZ_NN 84_CD (_( G_NNP 105_CD S_NNP )_) ,_, which_WDT has_VBZ only_RB 10_CD %_NN
          of_IN the_DT GTPase_NNP activity_NN of_IN wild_JJ type_NN FtsZ_NNP over_IN the_DT entire_JJ
          range_NN from_IN 30_CD to_TO 44_CD °_NN C_NNP [_NN 17_CD ,_, 19_CD ]_NN ._. In_IN spite_NN of_IN this_DT greatly_RB
          reduced_VBN GTPase_NNP in_IN vitro_NN ,_, FtsZ_NNP 84_CD can_MD function_VB for_IN cell_NN
          division_NN at_IN 30_CD °_NN C_NNP ,_, and_CC also_RB at_IN 42_CD °_NN C_NNP when_WRB over-expressed_JJ
          2_CD -_: 3_CD fold_VB [_NN 20_CD ,_, 21_CD ]_NN ,_, or_CC when_WRB ZipA_NNP is_VBZ overexpressed_JJ 2_CD -_: fold_VB
          [_NN 22_CD ]_NN ._. FtsZ_NNP 2_CD (_( D_NNP 212_CD G_NNP )_) has_VBZ 200_CD -_: fold_VB lower_JJR GTPase_NNP than_IN wild_JJ
          type_NN [_NN 23_CD ]_NN ,_, yet_RB it_PRP can_MD support_VB division_NN when_WRB
          overexpressed_JJ (_( however_RB ,_, this_DT division_NN occurs_VBZ with_IN a_DT
          mini-cell_JJ phenotype_NN at_IN 30_CD °_NN C_NNP ,_, and_CC cell_NN lysis_NNS occurs_VBZ at_IN
          42_CD °_NN C_NNP )_) [_NN 24_CD ]_NN ._. FtsZ_NNP 1_CD (_( A_DT 70_CD T_NN )_) and_CC FtsZ_NNP 100_CD (_( A_DT 81_CD V_NNP /_NN F_NN 268_CD C_NNP -_: it_PRP is_VBZ
          apparently_RB the_DT A_DT 81_CD V_NNP substitution_NN that_WDT reduces_VBZ the_DT GTPase_NNP ,_,
          since_IN F_NN 268_CD C_NNP has_VBZ near_IN wild_JJ type_NN activity_NN [_NN 25_CD ]_NN )_) have_VBP about_IN
          15_CD %_NN wild_JJ type_NN GTPase_NNP activity_NN and_CC can_MD support_VB cell_NN
          division_NN [_NN 25_CD ]_NN ._. Our_PRP$ present_JJ study_NN has_VBZ identified_VBN one_CD
          additional_JJ mutant_JJ ,_, D_NNP 269_CD A_DT ,_, that_WDT is_VBZ capable_JJ of_IN supporting_VBG
          cell_NN division_NN ,_, but_CC has_VBZ lost_VBN 90_CD %_NN of_IN its_PRP$ GTPase_NNP activity_NN ._.
          Most_JJS of_IN these_DT mutant_JJ proteins_NNS seem_VBP to_TO have_VB normal_JJ
          assembly_NN in_IN vitro_NN ._.
          The_DT ability_NN of_IN these_DT five_CD mutants_NNS to_TO function_VB in_IN cell_NN
          division_NN is_VBZ surprising_JJ ,_, and_CC raises_VBZ two_CD possibilities_NNS ._. One_CD
          is_VBZ that_IN GTP_NNP hydrolysis_NNS may_MD be_VB substantially_RB moderated_VBN in_IN
          vivo_NN ._. For_IN example_NN ,_, the_DT polymer_NN structure_NN in_IN vivo_NN (_( still_RB
          unknown_JJ )_) might_MD impose_VB a_DT new_JJ rate-limiting_JJ step_NN in_IN
          hydrolysis_NNS ,_, which_WDT is_VBZ lower_JJR even_RB than_IN the_DT hydrolysis_NNS rate_NN
          of_IN the_DT mutants_NNS in_IN vitro_NN ._. Alternatively_RB ,_, the_DT GTPase_NNP
          activity_NN in_IN vitro_NN may_MD be_VB ten_CD times_NNS higher_RBR than_IN actually_RB
          needed_VBN for_IN division_NN ._. In_IN vivo_NN experiments_NNS will_MD be_VB needed_VBN
          to_TO address_VB this_DT question_NN further_RB ._.
        
        
          Curved_NNP and_CC straight_JJ protofilaments_NNS ,_, and_CC mutations_NNS
          contacting_VBG GTP_NNP
          In_IN a_DT recent_JJ study_NN [_NN 15_CD ]_NN we_PRP found_VBD that_IN FtsZ_NNP
          protofilaments_NNS could_MD adopt_VB either_CC a_DT straight_JJ or_CC curved_JJ
          conformation_NN ._. The_DT straight_JJ conformation_NN was_VBD seen_VBN in_IN
          single_JJ protofilaments_NNS assembled_VBN from_IN purified_JJ FtsZ_NNP with_IN
          GTP_NNP or_CC the_DT slowly_RB hydrolyzable_JJ analog_NN GMPCPP_NNP ,_, and_CC in_IN
          protofilament_NN sheets_NNS assembled_VBN with_IN DEAE_NNP dextran_NN ._. The_DT
          curved_JJ conformation_NN generated_VBD tubular_JJ polymers_NNS ,_, which_WDT
          were_VBD assembled_VBN with_IN DEAE_NNP dextran_NN and_CC GDP_NNP ._. We_PRP concluded_VBD
          that_IN the_DT straight_JJ and_CC curved_JJ conformations_NNS were_VBD favored_VBN
          by_IN GTP_NNP and_CC GDP_NNP ,_, respectively_RB ._.
          We_PRP therefore_RB expected_VBD that_IN mutations_NNS that_WDT severely_RB
          blocked_VBN GTP_NNP hydrolysis_NNS would_MD assemble_VB tubes_NNS in_IN GDP_NNP ,_, but_CC
          that_DT assembly_NN in_IN GTP_NNP would_MD give_VB only_RB straight_JJ
          protofilaments_NNS ._. All_DT of_IN these_DT mutants_NNS formed_VBD tubes_NNS in_IN the_DT
          presence_NN of_IN DEAE_NNP dextran_NN and_CC GDP_NNP ,_, as_IN expected_VBN ._. The_DT
          straight_JJ conformation_NN was_VBD preferred_VBN for_IN G_NNP 105_CD S_NNP (_( FtsZ_NNP 84_CD )_) in_IN
          GTP_NNP and_CC DEAE_NNP dextran_NN ,_, also_RB as_IN expected_VBN ._. However_RB ,_, the_DT
          other_JJ three_CD GTP-contact_NNP mutants_NNS (_( D_NNP 45_CD A_DT ,_, D_NNP 209_CD A_DT ,_, D_NNP 212_CD A_DT )_)
          preferred_VBN to_TO make_VB tubes_NNS even_RB in_IN GTP_NNP ._. This_DT did_VBD not_RB agree_VB
          with_IN our_PRP$ initial_JJ expectations_NNS that_WDT reduced_VBD GTP_NNP hydrolysis_NNS
          would_MD lock_VB the_DT protofilaments_NNS into_IN the_DT straight_JJ
          conformation_NN ._.
          A_DT recent_JJ paper_NN has_VBZ proposed_VBN that_IN hydrolysis_NNS of_IN GTP_NNP
          results_NNS in_IN a_DT substantial_JJ movement_NN of_IN the_DT T_NN 3_CD loop_NN ,_, and_CC
          suggested_VBD that_IN this_DT movement_NN might_MD be_VB involved_VBN in_IN the_DT
          transition_NN to_TO the_DT curved_JJ conformation_NN [_NN 26_CD ]_NN ._. D_NNP 45_CD is_VBZ
          adjacent_JJ to_TO the_DT T_NN 3_CD loop_NN ,_, so_RB removal_NN of_IN its_PRP$ side_NN chain_NN
          might_MD permit_VB movements_NNS similar_JJ to_TO those_DT that_WDT occur_VBP when_WRB
          the_DT γ-phosphate_JJ is_VBZ removed_VBN ._. The_DT positions_NNS of_IN D_NNP 209_CD and_CC
          D_NNP 212_CD are_VBP less_RBR certain_JJ ,_, but_CC they_PRP are_VBP likely_JJ close_RB to_TO or_CC in_IN
          contact_NN with_IN the_DT T_NN 3_CD loop_NN of_IN the_DT adjacent_JJ subunit_NN ._. We_PRP
          suggest_VBP the_DT hypothesis_NNS that_WDT removal_NN of_IN any_DT of_IN the_DT side_NN
          chains_NNS in_IN this_DT region_NN may_MD permit_VB movement_NN of_IN the_DT T_NN 3_CD loop_NN
          into_IN the_DT GDP_NNP conformation_NN ,_, similar_JJ to_TO removal_NN of_IN the_DT
          γ-phosphate_JJ ._.
        
        
          The_DT mystery_NN of_IN lateral_NN contacts_NNS
          Our_PRP$ initial_JJ goal_NN in_IN making_VBG the_DT lateral_NN mutants_NNS was_VBD to_TO
          target_VB amino_JJ acids_NNS making_VBG lateral_NN contacts_NNS between_IN
          protofilaments_NNS ._. We_PRP expected_VBD some_DT of_IN these_DT mutants_NNS to_TO
          disrupt_VB assembly_NN of_IN sheets_NNS and_CC /_NN or_CC tubes_NNS ,_, and_CC we_PRP would_MD
          then_RB be_VB able_JJ to_TO test_VB whether_IN they_PRP also_RB disrupted_VBD cell_NN
          division_NN ._. Protofilament_NNP sheets_NNS have_VBP not_RB been_VBN demonstrated_VBN
          in_IN vivo_NN ,_, so_IN this_DT could_MD be_VB an_DT important_JJ test_NN of_IN whether_IN
          the_DT lateral_NN interactions_NNS are_VBP actually_RB used_VBN in_IN cell_NN
          division_NN ._. However_RB ,_, none_NN of_IN these_DT lateral_NN mutations_NNS seemed_VBD
          to_TO affect_VB the_DT assembly_NN of_IN sheets_NNS in_IN vitro_NN -_: sheets_NNS
          assembled_VBN normally_RB in_IN both_DT DEAE_NNP dextran_NN and_CC calcium_NN ,_, and_CC
          tube_NN assembly_NN was_VBD also_RB mostly_RB normal_JJ ._.
          A_DT closer_JJR examination_NN of_IN the_DT atomic_JJ structure_NN may_MD
          explain_VB why_WRB our_PRP$ lateral_NN mutants_NNS failed_VBD to_TO prevent_VB
          assembly_NN of_IN DEAE_NNP dextran_NN sheets_NNS in_IN vitro_NN ._. The_DT
          protofilaments_NNS in_IN both_DT sheets_NNS and_CC tubes_NNS assembled_VBN in_IN DEAE_NNP
          dextran_NN are_VBP spaced_JJ 5_CD ._. 3_CD -_: 5_CD ._. 4_LS nm_NN apart_RB [_NN 15_CD ,_, 27_CD ]_NN ,_, but_CC the_DT
          subunit_NN is_VBZ not_RB that_DT wide_JJ ._. The_DT widest_JJS aspect_NN of_IN the_DT FtsZ_NNP
          subunit_NN is_VBZ seen_VBN in_IN the_DT front_JJ view_NN ,_, i_NNP ._. e_SYM ._. ,_, as_IN presented_VBN in_IN
          Fig_NNP ._. 1_LS ._. Most_JJS of_IN the_DT amino_JJ acids_NNS that_IN we_PRP mutated_VBN could_MD
          only_RB make_VB contact_NN if_IN the_DT subunits_NNS were_VBD spaced_JJ 4_CD -_: 4_CD ._. 5_CD nm_NN
          apart_RB ._. The_DT only_JJ structure_NN that_WDT could_MD bridge_VB a_DT 5_CD ._. 3_CD nm_NN
          spacing_VBG is_VBZ the_DT N-_NNP terminal_NN segment_NN ,_, which_WDT is_VBZ highly_RB
          extended_VBN in_IN 
          Methanococcus_NNP FtsZ_NNP and_CC perhaps_RB also_RB
          in_IN 
          E_NNP ._. coli_NNS ._. It_PRP seems_VBZ clear_JJ from_IN the_DT
          dimensional_NN analysis_NN that_IN the_DT lateral_NN residues_NNS we_PRP mutated_VBN
          could_MD not_RB form_VB the_DT bridges_NNS between_IN protofilaments_NNS in_IN the_DT
          DEAE_NNP dextran_NN sheets_NNS ._. The_DT N-_NNP terminal_NN helix_NN is_VBZ a_DT likely_JJ
          candidate_NN for_IN lateral_NN contacts_NNS in_IN these_DT sheets_NNS ._.
          There_EX is_VBZ ,_, however_RB ,_, a_DT second_JJ type_NN of_IN lateral_NN contact_NN
          that_WDT can_MD assemble_VB protofilament_NN sheets_NNS or_CC pairs_NNS with_IN a_DT
          much_RB closer_JJR spacing_VBG ._. We_PRP observed_VBD a_DT second_JJ form_NN of_IN
          protofilament_NN sheet_NN when_WRB assembled_VBN on_IN cationic_JJ lipid_NN
          monolayers_NNS ,_, in_IN which_WDT the_DT protofilaments_NNS were_VBD only_RB 3_CD ._. 7_CD nm_NN
          apart_RB [_NN 2_CD ]_NN ._. Löwe_NNP and_CC Amos_NNP [_NN 11_CD ]_NN showed_VBD pairs_NNS of_IN 
          Methanococcus_NNP FtsZ_NNP protofilaments_NNS
          with_IN a_DT ∼_NN 3_CD ._. 9_CD nm_NN spacing_VBG ._. We_PRP believe_VBP that_IN these_DT sheets_NNS and_CC
          pairs_NNS with_IN the_DT 3_CD ._. 7_CD -_: 3_CD ._. 9_CD nm_NN protofilament_NN spacing_VBG may_MD
          assemble_VB by_IN contacts_NNS of_IN the_DT lateral_NN surfaces_VBZ that_IN we_PRP
          mutated_VBN ,_, and_CC may_MD be_VB representative_NN of_IN an_DT essential_JJ
          polymer_NN in_IN vivo_NN ._.
          In_IN view_NN of_IN the_DT mostly_RB normal_JJ in_IN vitro_NN GTPase_NNP and_CC
          assembly_NN ,_, it_PRP was_VBD remarkable_JJ that_IN all_DT lateral_NN mutants_NNS
          failed_VBD to_TO complement_VB 
          ftsZ_NN 84_CD ._. So_RB far_RB this_DT failure_NN to_TO
          complement_VB has_VBZ only_RB been_VBN tested_VBN in_IN the_DT JFL_NNP 101_CD (_( pBS_NN 58_CD )_)
          system_NN ,_, but_CC the_DT reduced_VBN expression_NN of_IN the_DT mutant_JJ proteins_NNS
          suggests_VBZ a_DT possible_JJ dominant_JJ negative_JJ effect_NN ._. These_DT
          lateral_NN surfaces_VBZ may_MD therefore_RB be_VB important_JJ for_IN function_NN
          in_IN cell_NN division_NN ._. One_CD possibility_NN is_VBZ that_IN they_PRP could_MD
          provide_VB the_DT binding_JJ sites_NNS for_IN accessory_JJ proteins_NNS ._.
          However_RB ,_, FtsA_NNP [_NN 13_CD ,_, 28_CD ,_, 29_CD ,_, 30_CD ]_NN and_CC ZipA_NNP [_NN 31_CD ,_, 32_CD ,_, 33_CD ]_NN
          are_VBP the_DT only_RB two_CD proteins_NNS known_VBN to_TO bind_NN directly_RB to_TO FtsZ_NNP ,_,
          and_CC they_PRP bind_NN to_TO the_DT highly_RB conserved_JJ C-_NNP terminal_NN peptide_NN
          [_NN 34_CD ]_NN ._. An_DT alternative_NN is_VBZ that_IN these_DT lateral_NN surfaces_VBZ
          mediate_VB association_NN of_IN protofilaments_NNS with_IN each_DT other_JJ ,_, to_TO
          form_VB protofilament_NN pairs_NNS or_CC small_JJ sheets_NNS ._. These_DT would_MD
          likely_RB correspond_VB to_TO the_DT in_IN vitro_NN structures_NNS with_IN 3_CD ._. 7_CD -_: 3_CD ._. 9_CD
          nm_NN spacing_VBG ._.
          Wang_NNP et_CC al_NN ._. ,_, have_VBP recently_RB described_VBN 13_CD site_NN directed_VBD
          mutants_NNS of_IN 
          ftsZ_NN in_IN 
          Caulobacter_NNP crescentus_JJ [_NN 35_CD ]_NN ,_, and_CC
          tested_VBD them_PRP in_IN a_DT strain_NN in_IN which_WDT the_DT genomic_JJ wild_JJ type_NN 
          ftsZ_NN could_MD be_VB fully_RB expressed_VBN or_CC
          completely_RB suppressed_VBN ._. They_PRP targeted_VBD clusters_NNS of_IN adjacent_JJ
          residues_NNS containing_VBG two_CD or_CC more_RBR charged_JJ residues_NNS ,_, which_WDT
          were_VBD changed_VBN to_TO alanine_NN ._. Six_CD of_IN their_PRP$ mutants_NNS were_VBD fully_RB
          able_JJ to_TO support_VB cell_NN division_NN ,_, and_CC were_VBD listed_VBN as_IN wild_JJ
          type_NN in_IN phenotype_NN ._. Four_CD were_VBD not_RB able_JJ to_TO support_VB cell_NN
          division_NN and_CC were_VBD listed_VBN as_IN recessive-lethal_JJ ._. Each_DT of_IN
          these_DT mutations_NNS did_VBD ,_, however_RB ,_, cause_VB significant_JJ
          disruptions_NNS in_IN division_NN when_WRB expressed_VBD with_IN wild_JJ type_NN 
          ftsZ_NN ,_, so_IN they_PRP had_VBD a_DT partially_RB
          dominant_JJ effect_NN ._. Three_CD mutations_NNS were_VBD dominant-lethal_JJ ,_, as_IN
          was_VBD a_DT G_NNP 109_CD S_NNP mutant_JJ designed_VBD to_TO duplicate_VB the_DT 
          E_NNP ._. coli_NNS ftsZ_NN 84_CD ._.
          Two_CD of_IN these_DT mutants_NNS are_VBP particularly_RB relevant_JJ to_TO our_PRP$
          study_NN ._. Their_PRP$ DE_NNP 254_CD AA_NN includes_VBZ our_PRP$ E_NNP 250_CD A_DT ._. They_PRP listed_VBD it_PRP
          as_IN lethal-recessive_JJ ,_, although_IN noting_VBG that_IN it_PRP produced_VBD
          filamentous_JJ cells_NNS with_IN constrictions_NNS when_WRB expressed_VBD along_IN
          with_IN wild_JJ type_NN 
          ftsZ_NN ._. Their_PRP$ ability_NN to_TO obtain_VB
          transformants_NNS expressing_VBG the_DT mutant_JJ protein_NN contrasts_VBZ
          with_IN our_PRP$ results_NNS that_IN the_DT only_JJ transformants_NNS we_PRP obtained_VBD
          had_VBD significantly_RB reduced_VBN expression_NN levels_NNS of_IN the_DT mutant_JJ
          protein_NN ._. It_PRP may_MD be_VB that_IN the_DT aberrations_NNS induced_VBN by_IN this_DT
          mutant_JJ protein_NN were_VBD sufficient_JJ select_VB for_IN down-regulated_JJ
          expression_NN from_IN the_DT pGS_NN 58_CD vector_NN ,_, or_CC the_DT aberrations_NNS may_MD
          be_VB more_RBR severe_JJ in_IN 
          E_NNP ._. coli_NNS ._. A_DT second_JJ mutation_NN of_IN Wang_NNP
          et_CC al_NN ._. ,_, demonstrate_VB mutations_NNS can_MD have_VB very_RB different_JJ
          phenotypes_NNS in_IN different_JJ species_NNS ._. In_IN 
          Caulobacter_NNP G_NNP 109_CD S_NNP was_VBD
          dominant-lethal_JJ ,_, while_IN in_IN 
          E_NNP ._. coli_NNS the_DT corresponding_JJ G_NNP 104_CD S_NNP (_( 
          ftsZ_NN 84_CD )_) has_VBZ a_DT wild_JJ type_NN phenotype_NN
          at_IN 30_CD °_NN C_NNP ,_, and_CC can_MD support_VB cell_NN division_NN at_IN 42_CD °_NN C_NNP when_WRB
          overexpressed_JJ ._.
        
      
      
        Conclusions_NNP
        We_PRP have_VBP tested_VBN 16_CD site-directed_JJ mutants_NNS of_IN 
        E_NNP ._. coli_NNS FtsZ_NNP for_IN assembly_NN and_CC GTPase_NNP
        activity_NN in_IN vitro_NN ,_, and_CC for_IN whether_IN they_PRP can_MD function_VB in_IN
        vivo_NN to_TO complement_VB 
        ftsZ_NN 84_CD ._. Mutations_NNP on_IN the_DT front_NN and_CC
        back_RB of_IN the_DT FtsZ_NNP protofilament_NN were_VBD mostly_RB benign_JJ :_: they_PRP had_VBD
        normal_JJ in_IN vitro_NN assembly_NN ,_, and_CC could_MD complement_VB 
        ftsZ_NN 84_CD ._. Several_JJ of_IN these_DT ,_, however_RB ,_,
        had_VBD significantly_RB reduced_VBN in_IN vitro_NN GTPase_NNP ,_, demonstrating_VBG
        that_IN the_DT high_JJ level_NN of_IN GTPase_NNP is_VBZ not_RB essential_JJ for_IN assembly_NN
        or_CC function_NN in_IN vivo_NN ._. Another_DT class_NN of_IN mutations_NNS altered_VBD
        residues_NNS contacting_VBG the_DT GTP_NNP ._. These_DT could_MD all_DT assemble_VBP in_IN
        DEAE_NNP dextran_NN ,_, although_IN with_IN some_DT abnormalities_NNS ,_, and_CC they_PRP
        had_VBD <_NN 10_CD %_NN of_IN the_DT wild_JJ type_NN GTPase_NNP ._. These_DT mutants_NNS failed_VBD
        to_TO complement_VB 
        ftsZ_NN 84_CD when_WRB expressed_VBD on_IN pBS_NN 58_CD ._. A_DT
        third_JJ class_NN of_IN mutations_NNS mapped_VBN to_TO the_DT sides_NNS of_IN
        protofilaments_NNS ._. These_DT lateral_NN mutations_NNS did_VBD not_RB interfere_VB
        with_IN GTPase_NNP nor_CC with_IN assembly_NN of_IN protofilaments_NNS ,_, and_CC
        surprisingly_RB showed_VBD mostly_RB normal_JJ assembly_NN in_IN DEAE_NNP dextran_NN ._.
        We_PRP conclude_VBP that_IN these_DT lateral_NN surfaces_VBZ are_VBP not_RB involved_VBN in_IN
        assembly_NN of_IN the_DT DEAE_NNP dextran_NN polymers_NNS ._. However_RB ,_, four_CD
        mutations_NNS on_IN the_DT right_JJ side_NN and_CC two_CD on_IN the_DT left_NN failed_VBN to_TO
        give_VB clones_NNS that_WDT complement_VB 
        ftsZ_NN 84_CD ,_, suggesting_VBG that_IN these_DT
        lateral_NN surfaces_VBZ are_VBP important_JJ for_IN the_DT function_NN of_IN FtsZ_NNP in_IN
        cell_NN division_NN ._. These_DT lateral_NN surfaces_VBZ may_MD mediate_VB
        association_NN of_IN FtsZ_NNP protofilaments_NNS into_IN pairs_NNS or_CC small_JJ
        sheets_NNS ,_, although_IN with_IN a_DT structure_NN different_JJ from_IN the_DT in_IN
        vitro_NN polymers_NNS stabilized_VBN by_IN DEAE_NNP dextran_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Site-directed_NNP mutagenesis_NNS of_IN FtsZ_NNP
          All_DT FtsZ_NNP mutants_NNS with_IN amino_JJ acid_NN substitutions_NNS were_VBD
          constructed_VBN by_IN an_DT overlap_VB extension_NN PCR_NNP method_NN [_NN 36_CD ]_NN ._. We_PRP
          used_VBD genomic_JJ DNA_NNP for_IN a_DT template_NN ,_, and_CC for_IN each_DT mutant_JJ
          transcribed_JJ the_DT complete_JJ 
          ftsZ_NN sequence_NN (_( adding_VBG NdeI_NNP and_CC
          BamHI_NNP cloning_VBG sites_NNS at_IN the_DT ends_NNS )_) using_VBG error-correcting_JJ
          Pfu_NNP polymerase_NN [_NN 37_CD ]_NN and_CC outward-facing_JJ primers_NNS
          containing_VBG the_DT desired_VBN mutations_NNS ._. Mutated_NNP 
          ftsZ_NN genes_NNS were_VBD cloned_VBN into_IN the_DT
          pET_NN 11_CD plasmid_NN for_IN expression_NN of_IN FtsZ_NNP ,_, permitting_VBG
          purification_NN of_IN the_DT mutant_JJ protein_NN ._.
          The_DT FtsZ_NNP mutants_NNS were_VBD all_DT created_VBN originally_RB in_IN the_DT
          pET_NN expression_NN vector_NN ._. In_IN order_NN to_TO test_VB whether_IN they_PRP
          could_MD function_VB in_IN vivo_NN ,_, we_PRP transferred_VBD the_DT mutations_NNS to_TO
          the_DT plasmid_NN pBS_NN 58_CD (_( provided_VBN by_IN Dr_NNP ._. Joe_NNP Lutkenhaus_NNP ,_,
          University_NNP of_IN Kansas_NNP Medical_NNP Center_NNP ,_, Kansas_NNP )_) ._. To_TO
          construct_VB a_DT pBS_NN 58_CD 
          ftsZ_NN mutant_JJ plasmid_NN (_( pBS_NN 58_CD 
          ftsZ_NN mut_NN )_) ,_, the_DT EcoRI_NNP and_CC BstEII_NNP
          fragment_NN of_IN 
          ftsZ_NN in_IN pBS_NN 58_CD was_VBD replaced_VBN with_IN the_DT
          same_JJ part_NN of_IN 
          ftsZ_NN from_IN pET-_NN 
          ftsZ_NN mut_NN ._. Because_IN EcoRI_NNP and_CC BstEII_NNP
          sites_NNS are_VBP not_RB unique_JJ in_IN pBS_NN 58_CD and_CC pET_NN ,_, additional_JJ cloning_VBG
          steps_NNS were_VBD needed_VBN ._. A_DT 2_CD ._. 4_CD kb_NN HindIII_NNP fragment_NN from_IN pBS_NN 58_CD
          that_WDT contains_VBZ the_DT whole_JJ 
          ftsZ_NN gene_NN was_VBD first_JJ subcloned_JJ into_IN
          vector_NN Litmus_NNP 38_CD (_( New_NNP England_NNP Biolabs_NNP )_) whose_WP$ EcoRI_NNP site_NN
          has_VBZ been_VBN deleted_VBN ,_, and_CC created_VBD a_DT plasmid_NN Litmus_NNP 38_CD (_( RI_NNP )_) +_NN H_NNP 3_CD ._.
          The_DT EcoRI_NNP and_CC BstEII_NNP fragment_NN with_IN a_DT desired_VBN mutation_NN
          from_IN pET-_NN 
          ftsZ_NN mut_NN was_VBD put_VBN into_IN
          Litmus_NNP 38_CD (_( RI_NNP )_) +_NN H_NNP 3_CD precut_NN by_IN the_DT same_JJ enzymes_NNS ._. Finally_RB ,_, the_DT
          HindIII_NNP fragment_NN from_IN Litmus_NNP 38_CD (_( RI_NNP )_) +_NN H_NNP 3_CD mut_NN was_VBD ligated_JJ into_IN
          pBS_NN 58_CD whose_WP$ HindIII_NNP segment_NN had_VBD been_VBN removed_VBN ._. The_DT
          orientation_NN of_IN gene_NN in_IN the_DT resulting_VBG plasmid_NN pBS_NN 58_CD 
          ftsZ_NN mut_NN was_VBD examined_VBN by_IN EcoRI_NNP
          digestion_NN ._.
          Ten_CD mutants_NNS were_VBD sequenced_JJ from_IN the_DT pET_NN vector_NN :_: D_NNP 45_CD A_DT ,_,
          A_DT 70_CD T_NN ,_, D_NNP 86_CD K_NNP ,_, D_NNP 158_CD A_DT ,_, D_NNP 212_CD A_DT ,_, E_NNP 238_CD A_DT ,_, E_NNP 250_CD A_DT ,_, D_NNP 269_CD A_DT ,_, E_NNP 274_CD A_DT ,_, and_CC
          D_NNP 299_CD A_DT ._. Nine_CD mutants_NNS were_VBD sequenced_JJ from_IN pBS_NN 58_CD :_: A_DT 70_CD T_NN ,_,
          D_NNP 96_CD A_DT ,_, D_NNP 158_CD A_DT ,_, D_NNP 166_CD K_NNP /_NN F_NN 268_CD V_NNP ,_, D_NNP 187_CD A_DT ,_, D_NNP 209_CD A_DT ,_, S_NNP 245_CD F_NN ,_, D_NNP 269_CD A_DT and_CC
          E_NNP 274_CD A_DT ._. In_IN each_DT case_NN we_PRP sequenced_JJ approximately_RB 600_CD -_: 700_CD bp_NN
          around_IN the_DT mutation_NN ._. Only_RB one_CD showed_VBD a_DT change_NN other_JJ than_IN
          the_DT desired_VBN mutation_NN ._. D_NNP 166_CD K_NNP also_RB contained_VBD the_DT mutation_NN
          F_NN 268_CD V_NNP ;_: since_IN this_DT is_VBZ a_DT conservative_JJ substitution_NN ,_, and_CC
          since_IN the_DT similar_JJ F_NN 268_CD C_NNP (_( Z_NNP 114_CD )_) is_VBZ benign_JJ [_NN 38_CD ]_NN ,_, we_PRP do_VBP not_RB
          think_VB the_DT extra_JJ mutation_NN is_VBZ important_JJ ._.
        
        
          Quantitation_NNP of_IN FtsZ_NNP expression_NN
          Bacterial_NNP cultures_NNS ,_, including_VBG strains_NNS transformed_VBN with_IN
          pBS_NN 58_CD carrying_VBG various_JJ alleles_NNS of_IN 
          ftsZ_NN ,_, were_VBD either_CC grown_VBN to_TO A_DT 600_CD =_SYM
          0_CD ._. 5_CD -_: 0_CD ._. 7_CD at_IN 30_CD °_NN ,_, or_CC grown_VBN to_TO A_DT 600_CD ∼_NN 0_CD ._. 15_CD at_IN 30_CD °_NN ,_, then_RB
          grown_VBN for_IN 90_CD minutes_NNS at_IN 42_CD °_NN ._. All_DT cultures_NNS were_VBD grown_VBN in_IN
          LB_NNP (_( +_NN 100_CD μg_NN /_NN mL_NN spectinomycin_NN if_IN necessary_JJ )_) ._. Harvesting_NNP
          and_CC extraction_NN of_IN the_DT cultures_NNS and_CC quantitation_NN of_IN FtsZ_NNP
          levels_NNS in_IN these_DT extracts_NNS was_VBD carried_VBN out_IN as_IN described_VBN [_NN
          14_CD ]_NN ,_, except_IN that_DT FtsZ_NNP levels_NNS were_VBD compared_VBN to_TO total_VB
          protein_NN levels_NNS instead_RB of_IN cell_NN numbers_NNS ._. Total_JJ protein_NN
          levels_NNS in_IN the_DT SDS_NNP extracts_NNS were_VBD determined_VBN by_IN BCA_NNP assay_NN
          (_( Pierce_NNP )_) after_IN removing_VBG the_DT reducing_VBG reagent_NN from_IN SDS_NNP
          buffer_NN by_IN precipitating_VBG protein_NN from_IN the_DT extract_NN with_IN 10_CD %_NN
          trichloroacetic_JJ acid_NN ,_, washing_VBG in_IN 10_CD %_NN trichloroacetic_JJ acid_NN
          and_CC resuspending_VBG the_DT pellet_NN in_IN 0_CD ._. 1_CD N_NNP NaOH_NNP ._. This_DT procedure_NN
          recovered_VBD >_NN 95_CD %_NN of_IN control_NN protein_NN from_IN SDS_NNP sample_NN
          buffer_NN over_IN the_DT range_NN of_IN protein_NN concentrations_NNS
          recommended_VBD for_IN use_NN in_IN the_DT BCA_NNP assay_NN (_( data_NNS not_RB
          shown_VBN )_) ._.
        
        
          Purification_NNP of_IN FtsZ_NNP
          FtsZ_NNP mutant_JJ proteins_NNS were_VBD over-expressed_JJ in_IN BL_NNP 21_CD (_( DE_NNP 3_LS )_)
          cells_NNS and_CC purified_JJ by_IN two_CD different_JJ approaches_NNS ._.
          Initially_RB ,_, we_PRP purified_JJ wild_JJ type_NN and_CC mutated_VBN FtsZ_NNP by_IN
          two-step_JJ ammonium_NN sulfate_NN precipitation_NN [_NN 14_CD ]_NN ._. Briefly_NNP ,_,
          cells_NNS were_VBD suspended_VBN in_IN 50_CD mM_NN Tris_NNP ,_, pH_NN 8_CD ._. 0_CD ,_, 100_CD mM_NN NaCl_NNP ,_,
          1_CD mM_NN EDTA_NNP ,_, 1_CD mM_NN PMSF_NNP ,_, treated_VBN with_IN 0_CD ._. 4_CD mg_NN /_NN mL_NN lysozyme_NN and_CC
          lysed_JJ by_IN freeze-thaw_JJ and_CC sonication_NN ._. We_PRP have_VBP subsequently_RB
          found_VBN that_IN lysis_NNS in_IN a_DT French_JJ pressure_NN cell_NN gives_VBZ a_DT much_RB
          more_RBR reproducible_JJ recovery_NN of_IN soluble_JJ proteins_NNS ,_, and_CC have_VBP
          used_VBN this_DT for_IN later_JJ preparations_NNS ._. We_PRP also_RB found_VBD that_IN
          inducing_VBG at_IN an_DT A_DT 600_CD of_IN 1_CD ._. 0_CD rather_RB than_IN 0_CD ._. 5_CD gave_VBD more_RBR
          soluble_JJ protein_NN ._. FtsZ_NNP was_VBD purified_JJ from_IN the_DT bacterial_JJ
          supernatant_NN by_IN discarding_VBG a_DT precipitate_NN at_IN 20_CD %_NN saturated_VBD
          ammonium_NN sulfate_NN ,_, then_RB precipitating_VBG the_DT remaining_VBG FtsZ_NNP
          by_IN raising_VBG the_DT ammonium_NN sulfate_NN level_NN to_TO 25_CD %_NN saturation_NN [_NN
          14_CD ]_NN ._. This_DT procedure_NN gives_VBZ an_DT excellent_JJ yield_NN of_IN pure_JJ ,_,
          active_JJ wild_JJ type_NN FtsZ_NNP [_NN 14_CD ]_NN ,_, and_CC was_VBD used_VBN for_IN most_JJS of_IN the_DT
          studies_NNS described_VBD below_IN with_IN no_DT additional_JJ steps_NNS ._.
          We_PRP later_RB found_VBD that_IN some_DT mutant_JJ FtsZs_NNP were_VBD not_RB
          efficiently_RB precipitated_VBD by_IN 25_CD %_NN ammonium_NN sulfate_NN ,_, so_IN we_PRP
          adopted_VBD a_DT method_NN using_VBG higher_JJR ammonium_NN sulfate_NN for_IN the_DT
          initial_JJ precipitation_NN ,_, followed_VBN by_IN DEAE_NNP chromatography_NN [_NN
          3_CD ,_, 19_CD ]_NN ._. FtsZ_NNP was_VBD precipitated_VBD by_IN adding_VBG ammonium_NN sulfate_NN
          to_TO 35_CD %_NN saturation_NN ._. The_DT resulting_VBG protein_NN pellet_NN was_VBD
          resuspended_JJ in_IN 10_CD ml_NN of_IN buffer_NN A_DT (_( 50_CD mM_NN Tris-_NNP HCl_NNP ,_, pH_NN 7_CD ._. 5_CD ,_,
          5_CD mM_NN MgCl_NNP 2_CD ,_, 0_CD ._. 1_CD mM_NN EDTA_NNP ,_, 0_CD ._. 5_CD mM_NN DTT_NNP ,_, 10_CD %_NN glycerol_NN and_CC 1_CD
          mM_NN PMSF_NNP )_) and_CC dialyzed_JJ against_IN 500_CD ml_NN of_IN buffer_NN A_DT
          overnight_JJ ._. The_DT sample_NN was_VBD loaded_VBN onto_IN a_DT DEAE-Sephacel_NNP
          column_NN at_IN 4_CD °_NN C_NNP and_CC eluted_JJ with_IN a_DT gradient_NN of_IN 0_CD ._. 05_CD -_: 1_CD M_NNP KCl_NNP
          in_IN buffer_NN A_DT ._. FtsZ_NNP eluted_JJ at_IN 0_CD ._. 4_CD M_NNP KCl_NNP ,_, separated_JJ from_IN a_DT
          later_JJ peak_NN containing_VBG nucleic_JJ acid_NN ._. The_DT FtsZ_NNP was_VBD desalted_JJ
          in_IN MEMK_NNP 6_CD ._. 5_LS (_( 100_CD mM_NN MES_NNP ,_, pH_NN 6_CD ._. 5_CD adjusted_VBN with_IN KOH_NNP ,_, 1_CD mM_NN
          EGTA_NNP ,_, 5_CD mM_NN Mg_NNP acetate_NN )_) and_CC stored_VBD at_IN -_: 80_CD °_NN C_NNP ._. SDS-PAGE_NNP
          showed_VBD several_JJ high_JJ molecular_JJ weight_NN contaminants_NNS in_IN the_DT
          FtsZ_NNP precipitated_VBD by_IN 35_CD %_NN ammonium_NN sulfate_NN ,_, and_CC these_DT were_VBD
          not_RB removed_VBN by_IN the_DT DEAE_NNP column_NN ._. The_DT 20_CD /_NN 25_CD %_NN ammonium_NN
          sulfate_NN protocol_NN seems_VBZ to_TO give_VB a_DT better_JJR purification_NN of_IN
          proteins_NNS that_WDT can_MD be_VB precipitated_VBD at_IN 25_CD %_NN ,_, but_CC the_DT
          alternative_JJ protocol_NN is_VBZ important_JJ for_IN some_DT mutants_NNS that_WDT
          do_VBP not_RB precipitate_NN completely_RB at_IN 25_CD %_NN ammonium_NN sulfate_NN ._.
          The_DT following_VBG proteins_NNS were_VBD purified_JJ by_IN the_DT DEAE-Sephacel_NNP
          procedure_NN for_IN GTPase_NNP assays_NNS :_: A_DT 70_CD T_NN (_( FtsZ_NNP 1_LS )_) ,_, D_NNP 158_CD A_DT ,_, D_NNP 269_CD A_DT
          and_CC G_NNP 105_CD S_NNP (_( FtsZ_NNP 84_CD )_) ._.
          Wild_NNP type_NN FtsZ_NNP was_VBD usually_RB about_IN 70_CD %_NN soluble_JJ when_WRB
          expressed_VBD in_IN BL_NNP 21_CD (_( DE_NNP 3_LS )_) ,_, and_CC the_DT bacteria_NNS were_VBD lysed_JJ with_IN
          the_DT French_JJ press_NN ._. Some_DT mutant_JJ proteins_NNS seemed_VBD less_RBR
          soluble_JJ ,_, giving_VBG from_IN 5_CD %_NN to_TO 40_CD %_NN soluble_JJ protein_NN (_( D_NNP 45_CD A_DT ,_,
          D_NNP 96_CD A_DT ,_, D_NNP 86_CD K_NNP ,_, D_NNP 209_CD A_DT ,_, E_NNP 238_CD A_DT ,_, D_NNP 166_CD K_NNP ,_, listed_VBN in_IN increasing_VBG
          order_NN of_IN solubility_NN )_) ._. Remarkably_NNP ,_, when_WRB the_DT pET_NN plasmids_NNS
          were_VBD expressed_VBN in_IN 
          E_NNP ._. coli_NNS C_NNP 41_CD ,_, a_DT modified_VBN BL_NNP 21_CD (_( DE_NNP 3_LS )_) [_NN
          12_CD ]_NN ,_, D_NNP 45_CD A_DT was_VBD expressed_VBN at_IN a_DT lower_JJR level_NN but_CC was_VBD 50_CD %_NN
          soluble_JJ ,_, and_CC all_DT other_JJ proteins_NNS were_VBD expressed_VBN at_IN a_DT high_JJ
          level_NN and_CC were_VBD >_NN 90_CD %_NN soluble_JJ ._.
        
        
          In_IN vitro_NN assembly_NN ,_, electron_NN microscopy_NN and_CC GTPase_NNP
          assay_NN
          All_DT in_IN vitro_NN assays_NNS were_VBD done_VBN in_IN MEMK_NNP 6_CD ._. 5_LS buffer_NN ._.
          Assembly_NN reactions_NNS contained_VBD 1_CD mg_NN /_NN ml_NN FtsZ_NNP (_( determined_VBN by_IN
          our_PRP$ calibrated_VBN BCA_NNP assay_NN [_NN 14_CD ]_NN )_) ,_, 2_CD mM_NN GTP_NNP or_CC GDP_NNP and_CC
          variable_JJ concentrations_NNS of_IN DEAE-dextran_NNP or_CC calcium_NN ._. The_DT
          reaction_NN mixture_NN was_VBD incubated_JJ on_IN ice_NN for_IN 5_CD -_: 10_CD min_NN ,_, then_RB
          at_IN 37_CD °_NN C_NNP for_IN 5_CD min_NN ,_, and_CC negatively_RB stained_JJ electron_NN
          microscope_NN specimens_NNS were_VBD prepared_VBN ._.
          Assembly_NNP in_IN calcium_NN was_VBD tested_VBN in_IN the_DT crude_NN lysed_JJ
          bacterial_JJ supernatants_NNS ,_, by_IN adding_VBG GTP_NNP to_TO 1_CD mM_NN and_CC calcium_NN
          chloride_NN to_TO 20_CD mM_NN ._. The_DT sample_NN was_VBD brought_VBN to_TO room_NN
          temperature_NN for_IN five_CD min_NN ._. Assembly_NNP of_IN FtsZ_NNP polymers_NNS was_VBD
          initially_RB indicated_VBN by_IN formation_NN of_IN a_DT gel_NN ,_, and_CC negative_JJ
          stain_VB electron_NN microscopy_NN confirmed_VBD a_DT network_NN of_IN
          protofilament_NN sheets_NNS in_IN most_JJS of_IN these_DT gelled_JJ samples_NNS (_( in_IN
          some_DT the_DT background_NN obscured_VBD any_DT structures_NNS )_) ._. The_DT most_RBS
          decisive_JJ indication_NN of_IN assembly_NN was_VBD obtained_VBN by_IN
          centrifugation_NN at_IN 100_CD ,_, 000_CD ×_NN g_SYM for_IN 30_CD min_NN ._. This_DT pelleted_JJ a_DT
          clean_JJ band_NN of_IN FtsZ_NNP in_IN the_DT gelled_JJ samples_NNS ,_, whereas_IN without_IN
          calcium_NN nothing_NN was_VBD pelleted_JJ ._.
          GTPase_NNP activity_NN was_VBD assayed_JJ as_IN described_VBN previously_RB [_NN
          14_CD ]_NN with_IN some_DT modifications_NNS ._. Briefly_NNP ,_, the_DT reaction_NN was_VBD
          started_VBN by_IN adding_VBG 3_CD μl_NN of_IN 10_CD mM_NN GTP_NNP (_( Sigma_NNP )_) and_CC 5_CD μCi_NN {_( α-_NN
          32_CD P_NN }_) GTP_NNP (_( 3000_CD Ci_NNP /_NN mmol_NN ,_, Amersham_NNP )_) to_TO 27_CD μl_NN of_IN FtsZ_NNP in_IN
          MEMK_NNP 6_CD ._. 5_LS and_CC incubated_JJ immediately_RB at_IN 37_CD °_NN C_NNP ._. To_TO terminate_VB
          the_DT reaction_NN ,_, 3_CD μl_NN of_IN the_DT reaction_NN mixture_NN was_VBD withdrawn_VBN
          every_DT three_CD minutes_NNS and_CC mixed_VBN with_IN 7_CD μl_NN of_IN 10_CD mM_NN EDTA_NNP in_IN
          50_CD mM_NN Tris-_NNP HCl_NNP ,_, pH_NN 8_CD ._. 0_CD (_( this_DT is_VBZ an_DT important_JJ modification_NN
          of_IN our_PRP$ previous_JJ protocol_NN ,_, as_IN the_DT EDTA_NNP stops_VBZ GTP_NNP
          hydrolysis_NNS )_) ._. One_CD microliter_NN of_IN this_DT mixture_NN was_VBD applied_VBN
          to_TO a_DT polyethyleneimine_NN cellulose_NN thin_JJ layer_NN
          chromatography_NN plate_NN and_CC developed_VBN in_IN 0_CD ._. 75_CD M_NNP KH_NNP 2_CD PO_NNP 4_CD ._.
          GDP_NNP produced_VBD was_VBD determined_VBN and_CC the_DT GTPase_NNP activity_NN was_VBD
          expressed_VBN as_IN mols_NNS GDP_NNP per_IN mol_NN FtsZ_NNP per_IN min_NN ._. GTPase_NNP of_IN
          mutant_JJ proteins_NNS were_VBD scaled_VBN as_IN a_DT percent_NN of_IN wild_JJ type_NN ,_,
          which_WDT was_VBD 6_CD ._. 5_CD mols_NNS GTP_NNP per_IN mol_NN FtsZ_NNP per_IN min_NN ._.
        
      
    
  
